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INTRODUCTION
The relationship between blood pressure (BP) and mortality has been of interest to epidemiologists and health professionals for several decades. Hypertension is a major risk factor for adverse clinical outcomes including cardiovascular disease, stroke and death. [1] [2] [3] Evidence from previous studies has suggested the associations between systolic BP (SBP) or diastolic BP (DBP) and risk of mortality. [4] [5] [6] [7] [8] [9] [10] Their results indicated a J-shaped 4 5 or U-shaped curve 6 phenomenon for the BP-mortality relationship. In addition, BP trajectories may have further impact on mortality. A recent study in Chinese normotensive diabetic people showed that low BP or a decline in BP was associated with an increased risk of all-cause mortality, 11 and Tielemans et al 12 also demonstrated that BP trajectories were strong predictors of all-cause mortality. Although previous studies have examined the association between BP and risk of mortality, most studies have been conducted in Western populations and the findings remain unclear. The Linxian General Population Trial prospectively collected data on clinical outcomes such as cardiovascular disease, cancer and other diseases. Herein, we reported the results of BP and risk of total, cardiovascular disease, stroke and cancer mortality from a prospective study of over 30-year follow-up in the Linxian General Population Trial Cohort in China. Moreover, we examined the potential effects of BP trajectory patterns during the period of 1985-1999 on sequent risk of mortality.
METHODS

Study population
Detailed information on the Linxian General Population Trial has been described previously. 13 Briefly, the General Population Trial enrolled individuals from the general population of four communes in Northern Linxian. Individuals were eligible if they were between 40 and 69 years, lived in one of the four communes and provided written informed consent. A total of 29 584 healthy adults were randomised and received one of eight daily vitamin/ mineral supplement combinations according to a one-half replicate of a 2 4 fractional factorial design for 5.25 years, beginning in March 1986. Individuals who had cancer or debilitating diseases were excluded.
In a primary analysis, we excluded participants (n=145) with an extremely low or high BP (those lower or higher than the mean BP±3 SDs), and a total of 29 439 individuals were included in the final analysis (13 125 men and 16 314 women). In a second analysis, we included individuals who had at least two measurements of BP during 1985-1999 (n=10 015; 4266 men and 5749 women) to examine the association between BP trajectory patterns and risk of total, cardiovascular disease, stroke and cancer mortality. All participants gave informed consent for the use of their data.
Data collection
Baseline characteristics data of our study population were obtained using a standard questionnaire. All participants underwent a physical examination in local village hospitals, as well as a questionnaire administered by trained study personnel and research technicians following a standardised protocol that included quality control measures. All participants had their weight and height measured by trained staff. Body weight and height were measured while subjects were not wearing shoes. Body mass index (BMI) was then calculated as weight in kilograms divided by height in metres squared (kg/m 2 ). According to WHO/National Heart, Lung and Blood Institute criteria, subjects were categorised as underweight (BMI <18. 5 14 We obtained demographic and lifestyle data through the questionnaire, including age at baseline, gender, smoking status, alcoholic beverage drinking status, family history of having any cancer and any medication intake. Smoking was defined as regular cigarette or pipe use for at least 6 months (including Cardiac risk factors and prevention ever or current smokers), and alcohol use was defined as any alcohol consumption in the past 12 months (including ever or current alcohol drinkers). Family history of having any cancer was considered positive if a cancer was reported in at least one first-degree relative. Medication intake was defined as using any drug regularly. In addition, we also collected information on previous chronic disease including cardiovascular disease, stroke, cirrhosis and diabetes mellitus.
Blood pressure
All subjects had their BP measured in a seated position after resting for 5 min using a mercury sphygmomanometer. SBP and DBP were measured as the first and fifth Korotkoff sounds, respectively. BP was measured three times about 5 min apart, and the mean of these three measures was used for analysis. BP was measured again in 1999 since the baseline, and the same procedure for BP measurement was used. In our study, we used two different metrics for BP to evaluate the association between BP and risk of mortality: (1) the baseline BP and (2) the BP trajectory patterns during 1985-1999. In the second analysis, we excluded patients who had BP of 140/90 mm Hg or higher at baseline.
Mortality follow-up
During the trial period (1986) (1987) (1988) (1989) (1990) (1991) , village doctors visited all participants monthly, and all endpoints were confirmed by an International Endpoints Review Committee consisting of American and Chinese experts in cytology, pathology, surgery and radiology. During the post-trial follow-up periods (after 1991), village doctors continued to visit all participants monthly, and new cancer cases and all causes of death were verified by a panel of Chinese experts. Diagnostic materials used in these expert reviews included case records, pathology and cytology slides, biochemical results, X-rays, ultrasound, endoscopy and surgery reports. Primary causes of death were identified by the International Classification of Disease, 10th Revision cardiovascular disease (I00-I25, I28-I59), stroke (I60-I69) and cancer (C00-C97).
Statistical analysis
All subjects were divided into six groups, including hypotension (SBP <90 15 Participants were censored at the last known follow-up date, death or 31 December 2014, whichever came first. In the BP trajectory analysis, the initial date for follow-up was defined from the most recent examination (1999). We tested the differences in six categories using non-parametric Kruskal-Wallis Test for continuous variables and X 2 test for categorical variables. We used Cox regression models to estimate HRs and 95% CIs for examining the association between BP and risk of total, cardiovascular disease, cancer mortality. We also tested the assumption of proportional risk for the Cox models by using cross-product terms (time × BP) and using Kaplan-Meier curves. Normotensive subjects were defined as a reference category in the analysis. Moreover, our analyses were adjusted for the following covariates: age at baseline (continuous variable), sex (men or women), BMI (continuous variable), education level (never or 1-5 years or primary school or tertiary high school or higher education or others), tobacco smoking (yes or no), alcohol drinking (yes or no), family history of cancer (yes or no), commune (Rencun, Yaocun, Hengshui or Donggang), pulse rate (continuous variable) and any medication intake (yes or no). Subgroup analyses were performed to examine whether the association varied by sex (men or women), age at baseline (<60 or ≥60), smoking (yes or no), alcohol drinking (yes or no), BMI (<18.5, 18.5-25.0 or ≥25.0) and follow-up duration (<3 or ≥3). Sensitivity analyses were also performed by excluding smokers or drinkers or patients who had pre-existing chronic disease or had extreme BMIs or were followed up less than 3 years. To address the possibility of residual confounding by measured variables, we first created a propensity score that reflected associations of BP with the other variables in a logistic regression model and then further adjusted for the propensity score in the Cox regression model. We also evaluated possible non-linear associations by comparing the fit of continuous models with and without BP quadratic terms using a likelihood ratio test, and graphed the association using the BP linear and quadratic terms relative to the 12.5th percentile (online supplementary figures 1 and 2). In a second analysis, we examined the associations between BP trajectory patterns and risk of total, cardiovascular disease, stroke and cancer mortality. Subjects with a stable BP of <120/80 mm Hg were regarded as a reference group. BP trajectory patterns were stable in normotension, normotension to prehypertension, normotension to hypertension, prehypertension to normotension, stable in prehypertension and prehypertension to hypertension.
All statistical analyses were performed using SAS V.9.2 (SAS Institute). All tests were two sided, and p<0.05 was considered statistically significant.
RESULTS
A total of 29 439 participants were included in the final analysis. During 582 925 person-years (mean: 19.8 person-years) of follow-up, 19 403 deaths (including 4692 from cardiovascular disease, 6247 from stroke and 5731 from cancer) were identified. Of the eligible subjects, more than half (55.4%) were women. Mean age at baseline was 51.9 years. According to the 1999 WHO/ISH guidelines, nearly 19% of participants were regarded as normotension, with 402 patients with hypotensive (1%), 11 031 patients with prehypertensive (38%) and 12 401 patients with hypertensive (42%). Patients with hypertensive were more likely to be older and to have lower education, were less commonly smokers and drinkers. Overweight/obesity was more prevalent among patients with hypertensive (table 1) . Table 2 shows HRs and 95% CIs for the associations between BP and risk of total, cardiovascular disease, stroke and cancer mortality. Compared with normotensive subjects, patients with prehypertensive and hypertensive had an increased risk of all-cause mortality, with HRs of 1.09 (95% CI 1.05 to 1.14) (prehypertension), 1.34 (95% CI 1.28 to 1.40) (stage 1 hypertension), 1.69 (95% CI 1.60 to 1.79) (stage 2 hypertension) and 2.14 (95% CI 2.01 to 2.28) (stage 3 hypertension), respectively. We also examined cause-specific mortality, and observed stronger associations for stroke mortality ( Subgroup analyses showed that the relationship between BP and all-cause mortality did not materially alter by age at baseline, sex, BMI, smoking, alcohol drinking and duration of follow-up (table 3) . Results appeared similar across subgroups by age at baseline, sex, smoking status and BMI. Significant associations were observed for hypotension and risk of total mortality among non-drinkers and individuals who had no family history of cancer, and the HRs were 1.20 (95% CI 1.02 to 1.40) and 1.25 (95% CI 1.06 to1.47), respectively. When stratified by duration of follow-up, stronger associations were observed for prehypertension/hypertension and all-cause mortality in the follow-up of 3 years and more.
Exclusion of smokers, drinkers, subjects who had pre-existing chronic disease or were followed up less than 3 years or had extreme BMIs (<18.5 or>40 kg/m 2 ) did not materially alter our findings. A similar relationship was also observed among non-smokers, non-drinkers, participants who had no pre-existing chronic disease or had extreme BMIs, or subjects with the follow-up of 3 years and more. Further adjustment for propensity score for BP in Cox models did not alter our findings (figure 1, online supplementary table 2). Figure 2 summaries the associations between BP trajectories and risk of total, cardiovascular disease, stroke and cancer mortality. Compared with persons who had a stable BP of <120/80 mm Hg, the adjusted HR for all-cause mortality was 1.22 (95% CI 1.12 to 1.34) for increase BP from <120/80 mm Hg to ≥140/90 mm Hg, and 1.36 (95% CI 1.23 to 1.51) for increase BP from 120-139/80-89 mm Hg to ≥140/90 mm Hg. No significant associations were observed between other BP trajectory patterns and total mortality. For cause-specific mortality, stronger associations were observed for cardiovascular disease and stroke mortality among subjects with development of incident hypertension, and we also found significant associations for cardiovascular disease mortality among subjects with stable prehypertension (HR=1.75, 95% CI 1.29 to 2.39) or from normotension to prehypertension (HR=1.32, 95% CI 1.04 to 1.68). No associations were observed in any BP trajectory pattern for cancer mortality. Subgroup analyses indicated slightly stronger associations between development of incident hypertension and total mortality in women (online supplementary table 3).
DISCUSSION
The present study examines the association between BP (at baseline and trajectory patterns) and risk of mortality in the Linxian General Population Trial Cohort. Overall, significant associations were observed for BP and risk of total, cardiovascular disease and stroke mortality. When compared with normotensive subjects, prehypertensive and hypertensive persons had a higher risk of all-cause, cardiovascular disease and stroke mortality. No associations were observed for cancer mortality. Sensitivity analyses by excluding smokers, alcohol drinkers, subjects who had extreme BMIs or previous chronic disease or followed up the first 3 years did not alter our findings. A BP trajectory analysis showed that individuals with increased BP from <120/80 mm Hg Figure 2 HRs for risk of mortality due to all cause, cardiovascular disease, stroke and cancer according to blood pressure (BP) trajectory patterns. Normotension: subjects with BP of less than 120/80 mm Hg; Prehypertension: subjects with BP of 120-139/80-89 mm Hg; Hypertension: subjects with BP ≥140/90 mm Hg. HRs and 95% CIs were calculated by adjustment for age at baseline, sex, BMI, commune, education level, tobacco smoking, alcohol drinking, family history of cancer, pulse rate and any drug intake. BMI, body mass index.
or 120-139/80-89 mm Hg to ≥140/90 mm Hg had an increased risk of total, cardiovascular disease and stroke mortality.
Our findings of positive associations for BP >120/80 mm Hg and risk of cardiovascular mortality were comparable to a previous study in Korea. A study of 1 235 246 individuals from the Korean Cancer Prevention Study has indicated J-curve associations between SBP and vascular mortality. 16 The Systolic Blood Pressure Intervention Trial 17 Research Group concluded that among patients at high risk for cardiovascular events but without diabetes mellitus, lowering SBP to a target goal of less than 120 mm Hg rather than <140 mm Hg could reduce 25% risk of major cardiovascular events and 43% of cardiovascular mortality. Several trials such as the Systolic Hypertension in the Elderly Program Trial 18 and the Systolic Hypertension in Europe trial 19 suggested the benefits of SBP targets below 150 mm Hg, and the Eighth Joint National Committee recommended SBP goal of lower than 150 mm Hg in the elderly. 20 This recommendation was primarily derived from two large randomised clinical trials. Some limitations of these studies should be considered, including the short median follow-up duration (only 2 years). Another limitation is that both studies were conducted in Japan where there is low incidence of coronary heart disease compared with other parts of the world and the result might extrapolate to the other regions. However, it is still controversial for the current BP targets. 21 Adequate control of elevated BP could help prevent cardiovascular events and mortality, and new concepts in hypertension management have been reported in several recent studies. [22] [23] [24] As expected, in our study, we observed no associations between hypertension and risk of cancer mortality. A number of epidemiological studies have indicated either positive or no associations for elevated BP and cancer mortality. [25] [26] [27] A pooled analysis of seven cohorts from Norway, Austria and Sweden has suggested a higher risk of cancer death with elevated BP. 27 However, there is little support for hypertension and cancer incidence or mortality in a cohort study of Japanese-American men in Hawaii. 25 The discrepancy in results between these studies may be explained by chance, unknown confounders, different study designs, differences in the study populations or the specific cancer types that dominate different populations.
One use of a single measurement of BP at baseline might contribute to an underestimated relative risk with regression dilution bias. 28 BP trajectory patterns over time may have greater power in predicting risk of total and cardiovascular mortality. Limited studies in China have examined the potential effect of longitudinal change in BP. In our study, we included participants with at least two measurements of BP to examine the potential
Cardiac risk factors and prevention Key messages
What is already known on this subject? ► A J-shaped association between systolic blood pressure (BP) or diastolic BP and all-cause mortality has been shown in previous studies.
What might this study add?
► In the present study, significant associations were observed for BP at baseline and risk of total, cardiovascular disease and stroke mortality. ► Individuals with increased BP from <120/80 mm Hg or 120-139/80-89 mm Hg to ≥140/90 mm Hg had an increased risk of total, cardiovascular disease and stroke mortality.
How might this impact on clinical practice?
► Adequate control of elevated BP could help prevent cardiovascular events and mortality, and our findings suggest that current BP targets could be reconsidered.
effect of BP trajectories. We observed development of hypertension conferred a higher risk of total, cardiovascular disease and stroke mortality. However, one possible interpretation is the relationship of elevated BP with vascular ageing, 29 and thus caused cardiovascular events and then results in death from these diseases.
Some caution is necessary in the interpretation of our results. In fact, smoking or alcohol drinking is associated with BP and an increased risk of mortality 30 and there is also a strong association between smoking and drinking habits. This suggested that smoking and drinking can distort the relationship between BP and risk of mortality. Moreover, a potential limitation for observational studies is the possibility for residual or uncontrolled confounding. We further excluded smokers and drinkers in our study to address this potential bias and results did not change. We further adjusted for a propensity score that reflected associations of BP with the other variables, which did not alter our results.
Our study had several important strengths, including its prospective design, large sample size, longitudinal patterns of change in BP during follow-up period, a homogeneous ethnic group and over 30 years follow-up. Our study also had several limitations. First, although we had information on tobacco smoking, alcohol drinking, education and BMI, we lacked information on other potential confounders, such as physical activity and total energy intake. As in other observational studies, our results could potentially reflect the confounding effect by physical activity or other lifestyle factors. Furthermore, in our study, we lacked information on antihypertensive drug use over time, which could affect our results. Second, some of our significant findings may also have been due to the number of tests that were not included in the prespecified hypotheses. Third, although persons with self-reported cancer, debilitating diseases (severe kidney and liver disease) were excluded from our study, we collected data of cardiovascular disease, stroke, cirrhosis and diabetes mellitus at baseline and results did not alter when exclusion of these chronic diseases. Finally, our subjects were composed of rural Chinese adults, and had fewer women smokers and drinkers than the general Chinese population, which may affect the generalisability of our results to other Chinese populations.
In summary, in this large prospective study, positive associations were observed for BP and risk of total, cardiovascular disease and stroke mortality. Prehypertension and hypertension were associated with an increased risk of total, cardiovascular disease and stroke mortality. BP trajectory patterns from normotensive levels to 140/90 mm Hg or higher were associated with increased risk of total, cardiovascular disease and stroke mortality. Further studies are needed to confirm these findings in other ethnic/regional populations.
